Actualités Sernova Biotherapeutics Inc - SVA | Actions Toronto Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

LONDON, Ontario and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics

LONDON, Ontario and BOSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB:...

Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders

LONDON, Ontario and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF...

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

LONDON, Ontario and BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF...

Sernova Update on Strategic Initiatives

Signed Letter of Intent with ‘Project REEM Ventures’ for Product Development and Commercialization in the...

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch...

Sernova Corp. Announces Appointment of New Chief Executive Officer

LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. (“Sernova” or...

Sinovac Completes Acquisition Aimed at Expanding Production Capacity

BEIJING, Feb. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced the...

Sinovac Announces Exercise of Over-Allotment Option

BEIJING, Feb. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer...

Sinovac Announces Plan to Launch Offering of Common Shares

BEIJING, Jan. 20 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced that it...

Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease

BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced...

Sinovac's CEO Weidong Yin Presented with Annual Innovation Award by China Central Television

BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced...

Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009

BEIJING, Dec. 21 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced...

Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government

BEIJING, Dec. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical products in China, announced today...

Sinovac to Present at Piper Jaffray Health Care Conference

BEIJING, Nov. 24 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Sernova Biotherapeutics Inc (SVA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SVA Actualités

Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics

Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

Sernova Update on Strategic Initiatives

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

Sernova Corp. Announces Appointment of New Chief Executive Officer

Sinovac Completes Acquisition Aimed at Expanding Production Capacity

Sinovac Announces Exercise of Over-Allotment Option

Sinovac Announces Plan to Launch Offering of Common Shares

Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease

Sinovac's CEO Weidong Yin Presented with Annual Innovation Award by China Central Television

Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009

Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government

Sinovac to Present at Piper Jaffray Health Care Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Sernova Biotherapeutics Inc (SVA) Actualités

Sernova Biotherapeutics Inc (SVA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SVA Actualités

Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism

Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics

Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

Sernova Update on Strategic Initiatives

Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function

Sernova Corp. Announces Appointment of New Chief Executive Officer

Sinovac Completes Acquisition Aimed at Expanding Production Capacity

Sinovac Announces Exercise of Over-Allotment Option

Sinovac Announces Plan to Launch Offering of Common Shares

Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease

Sinovac's CEO Weidong Yin Presented with Annual Innovation Award by China Central Television

Sinovac Named One of China's Top 10 Most Competitive Companies Listed Overseas in 2009

Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government

Sinovac to Present at Piper Jaffray Health Care Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités